Skip to main content
Clinical Trials/CTRI/2017/04/008298
CTRI/2017/04/008298
Not yet recruiting
Phase 3

Comparison of best supportive care with or without 0.1% Topical Betamethasone valerate as a prophylactic agent for acute Radiation Dermatitis in Head and Neck Malignancies: a randomised controlled study

Dr Shyama Prem S0 sites150 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Patients getting Radical Radiotherapy in Head and Neck malignancies
Sponsor
Dr Shyama Prem S
Enrollment
150
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Shyama Prem S

Eligibility Criteria

Inclusion Criteria

  • Patients should be recieving radical RT,With ECOG 1\&2

Exclusion Criteria

  • Previously irradiated,connective tissue disorder,allergy to cream

Outcomes

Primary Outcomes

Not specified

Similar Trials